
New Biomarker 'Lgd' Shows Promise for Early T-Cell Leukemia Detection
Researchers have identified that Lgd (CC2D1A) is significantly upregulated and has altered nucleotide sequences in patients with T-cell acute lymphoblastic leukemia (T-ALL). This discovery, coupled with a strong positive correlation to Notch-1 expression, suggests Lgd could become a predictive indicator for the early identification of T-ALL.
By Pandey, Singh, Habib, Kushwaha, Mahdi

